Trademark: 79126686
Word
PASYLATION
Status
Registered
Status Code
708
Status Date
Tuesday, December 29, 2020
Serial Number
79126686
Registration Number
4483086
Registration Date
Tuesday, February 18, 2014
Mark Type
4000
Filing Date
Wednesday, October 17, 2012
Published for Opposition
Tuesday, December 3, 2013

Trademark Owner History
XL-protein GmbH - Original Registrant

Classifications
5 [ Pharmaceutical and veterinary preparations and preparations for human medical purposes for use in treating growth deficiencies, inflammation, infections, obesity, diabetes, malignancies, metabolic diseases, cancer, cardiovascular diseases, diseases of the CNS, eye diseases, bone diseases; [ sanitary preparations for medical purposes; dietetic substances adapted for medical use, namely, nutritional supplements containing proteins, peptides, food for babies; preparations for destroying vermin; fungicides, herbicides; ] pharmaceutical and diagnostic preparations for medical [, dental and forensic ] purposes and for purposes of [ forensic medicine and ] laboratory medicine, namely, pharmaceutical and diagnostic preparations for diagnosis, prevention, treatment or cure of growth deficiencies, inflammation, infections, obesity, diabetes, malignancies, metabolic diseases, cancer, cardiovascular diseases, diseases of the CNS, eye diseases, bone diseases; testing reagents in kit form for medical, [ dental and forensic ] purposes and for purposes of [ forensic medicine and ] laboratory medicine, namely, medical [ and forensic ] diagnostic reagents and assays for testing of body tissues and body fluids; chemical and biotechnological preparations for medical and diagnostic purposes, namely, reagents and solvents for sample preparation, modification and manipulation of cells and for performing of marking, separation, isolation, purification, amplification and/or analytical methods for biopolymers, in particular nucleic acids, proteins, macromolecules and biologically active substances for diagnostic purposes included in this class; medicaments for preventive, curative and palliative purposes for preventing, treating or curing of growth deficiencies, inflammation, infections, obesity, diabetes, malignancies, metabolic diseases, cancer, cardiovascular diseases, diseases of the CNS, eye diseases, bone diseases; medical biomarkers, in particular for preventative, diagnostic, prognostic or predictive purposes, namely, polypeptide sequences; [ medical preparations, namely, kits for laboratory medicine in particular for preventive, diagnostic, prognostic or predictive purposes, namely, diagnostic kits consisting primarily of proteins, buffers, and reagents for use in detecting growth deficiencies, inflammation, infections, obesity, diabetes, malignancies, metabolic diseases, cancer, cardiovascular diseases, diseases of the CNS, eye diseases, bone diseases; ] biomolecules for medical purposes, namely, proteins, peptides and small molecule drugs with conjugated polypeptide sequences for binding of active substances; medical preparations for analytical purposes, namely, reagents for detecting growth deficiencies, inflammation, infections, obesity, diabetes, malignancies, metabolic diseases, cancer, cardiovascular diseases, diseases of the CNS, eye diseases, bone diseases; preparations for health care, namely, for diagnosis, prevention, treatment, or cure of growth deficiencies, inflammation, infections, obesity, diabetes, malignancies, metabolic diseases, cancer, cardiovascular diseases, diseases of the CNS, eye diseases, bone diseases ]
1 [ Chemicals and biochemicals for research and laboratory purposes excluding for medical or veterinary purposes, and for industrial and scientific purposes; [ unprocessed artificial resins, unprocessed plastics; ] chemical and biological preparations for medical research and medical and scientific purposes ]
42 Scientific and technological services and research, namely, scientific research, analysis, testing, in the fields of chemistry, genetics, biology, biotechnology and biochemistry; [ technical services, namely, computer diagnostic services in the field of DNA, RNA and protein expression, detection and analysis and respective design services, in particular in the fields of chemistry, genetics, biology, biotechnology and biochemistry; industrial analysis and research services in the field of medical, dental, forensic and scientific research; design and development of computer hardware and software; ] services of a chemical and biochemical laboratory; scientific research including conducting of scientific examinations; and preparation of scientific opinions; quality checking, namely, quality evaluation services for the medical and pharmaceutical industry; [ design and development of programs for data processing; ] consultancy for scientific, laboratory and research purposes in the field of chemistry, genetics, biology, biotechnology and biochemistry; [ scientific services of a technical measuring and test laboratory; ] technological consulting services pertaining to scientific and industrial scientific research in the fields of generation, technical processing and technical analysis of biomaterials and medically relevant data
PAS YLATION
Color is not claimed as a feature of the mark.
The wording "PASYLATION" has no meaning in a foreign language.

Trademark Events
Feb 12, 2024
Teas Section 71 Received
Feb 18, 2023
Courtesy Reminder - Sec. 71 (10-Yr) E-Mailed
Nov 4, 2022
International Registration Renewed
Jul 2, 2022
New Representative At Ib Received
Sep 9, 2021
Invalidation Reviewed - No Action Required By Office
Aug 29, 2021
Partial Invalidation Of Reg Ext Protection Created
Feb 13, 2021
Partial Invalidation Processed By The Ib
Jan 1, 2021
Partial Invalidation Of Reg Ext Protection Sent To Ib
Dec 31, 2020
Invalidation Processed
Dec 29, 2020
Notice Of Acceptance Of Sec. 71 & 15 - E-Mailed
Dec 29, 2020
Registered - Partial Sec. 71 Accepted & Sec. 15 Ack.
Dec 27, 2020
Partial Invalidation Of Reg Ext Protection Created
Oct 2, 2020
Teas Response To Office Action-Post Reg Received
May 12, 2020
Post Registration Action Mailed - Sec. 71 & 15
Apr 6, 2020
Case Assigned To Post Registration Paralegal
Feb 18, 2020
Teas Section 71 & 15 Received
Feb 18, 2020
Teas Change Of Correspondence Received
Feb 18, 2020
Applicant/Correspondence Changes (Non-Responsive) Entered
Feb 18, 2020
Attorney/Dom.Rep.Revoked And/Or Appointed
Feb 18, 2020
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Feb 18, 2020
Teas Change Of Owner Address Received
Feb 18, 2019
Courtesy Reminder - Sec. 71 (6-Yr) E-Mailed
Jul 13, 2017
New Representative At Ib Received
Jun 27, 2014
Final Decision Transaction Processed By Ib
Jun 6, 2014
Final Disposition Notice Sent To Ib
Jun 6, 2014
Final Disposition Processed
May 18, 2014
Final Disposition Notice Created, To Be Sent To Ib
Feb 18, 2014
Registered-Principal Register
Dec 3, 2013
Official Gazette Publication Confirmation E-Mailed
Dec 3, 2013
Published For Opposition
Dec 2, 2013
Notification Processed By Ib
Nov 13, 2013
Notification Of Possible Opposition Sent To Ib
Nov 13, 2013
Notice Of Start Of Opposition Period Created, To Be Sent To Ib
Nov 13, 2013
Notification Of Notice Of Publication E-Mailed
Oct 30, 2013
Law Office Publication Review Completed
Oct 29, 2013
Approved For Pub - Principal Register
Sep 26, 2013
Teas/Email Correspondence Entered
Sep 26, 2013
Correspondence Received In Law Office
Sep 20, 2013
Assigned To Lie
Sep 19, 2013
Attorney/Dom.Rep.Revoked And/Or Appointed
Sep 19, 2013
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Sep 19, 2013
Teas Response To Office Action Received
Apr 23, 2013
Refusal Processed By Ib
Mar 28, 2013
Non-Final Action Mailed - Refusal Sent To Ib
Mar 28, 2013
Refusal Processed By Mpu
Mar 28, 2013
Non-Final Action (Ib Refusal) Prepared For Review
Mar 27, 2013
Non-Final Action Written
Mar 22, 2013
Application Filing Receipt Mailed
Mar 18, 2013
Assigned To Examiner
Mar 18, 2013
New Application Office Supplied Data Entered
Mar 15, 2013
Sn Assigned For Sect 66a Appl From Ib

Trademark Alertz updated from USPTO on 2030-01-24